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Clinical characteristics and diagnostic considerations in acquired renal
cystic disease. Acquired multiple bilateral cystic transformation of
kidneys has been increasingly noted in patients with long—standing renal
failure treated by chronic dialysis. To study the clinical characteristics
of this newly described disease and assess the utility of available
diagnostic methods, 130 patients with chronic renal failure (100 on
dialysis, 30 nondialyzed) were studied with ultrasonography and/or
computerized tomography (CT). Among patients on dialysis, 22% had
acquired renal cystic disease (ARCO), an additional 30% had one to
three solitary cysts, and 48% had no cysts. In nondialyzed patients, 7%
had ARCD, 53% had one to three solitary cysts, and 40% had no cysts.
Among these 130 chronic renal failure patients (nondialyzed and
dialyzed), 21 of 86 males compared to I of 44 females had ARCD (P <
0.001). Duration of dialysis therapy and age were greater in patients
with ARCD (49.8 8 months, 55 4 years, respectively) compared to
those with solitary cysts (28 6 months, 45 2 years) or no cysts (15
3 months, 42 2 years). The diagnostic accuracy of ultrasound (US)
was compared to CT. CT is purportedly 100% accurate in the charac-
terization of renal cysts. We are disappointed at the low level of
diagnostic accuracy for both CT and US in the detection of renal cysts
in chronic uremia. It appears both a negative CT and ultrasound are
necessary to absolutely exclude either ARCD or solitary cyst.
Extensive bilateral cystic transformation of the kidneys has
been increasingly reported in patients with chronic renal failure,
especially those treated with long—term hemodialysis therapy.
Acquired renal cystic disease (ARCD) was initially defined by
Dunnill, Millard and Oliver in 1977, who found bilateral cystic
disease at autopsy in 14 of 30 patients on long—term hemodial-
ysis [1]. Recent data which includes both surgical and autopsy
material has revealed the presence of cysts in eight to 95% of
patients maintained on chronic dialysis [2]. Among a total
reported population of 601 hemodialysis patients, renal cysts
have been documented in 262 for an overall prevalence rate of
43.6%. Since none of these patients had demonstrable renal
cystic disease at the onset of dialytic therapy, most authors
have assumed that such cysts were acquired as a consequence
of the maintenance hemodialysis procedure [1, 3—IS].
The etiology and natural history of acquired renal cystic
disease are unclear. This issue deserves clinical attention since
neoplasia occurs in 16% of the reported patients with cysts [16].
Presumably these tumors arise from foci of proliferating tubular
epithelial cells lining the walls of these acquired cysts.
Whether hemodialysis is a prerequisite for the development
of ARCD remains unresolved. The present study examines the
prevalence and time of onset of acquired renal cystic disease in
a large population with chronic renal failure. In addition,
ultrasonography and computerized tomography are compared
as diagnostic techniques for detection of acquired renal cystic
disease.
Methods
Patients
One hundred and thirty patients were evaluated. One hun-
dred hemo- and peritoneal dialysis patients, excluding those
with known underlying renal cystic disease (autosomal domi-
nant polycystic kidney disease, medullary sponge kidney, med-
ullary cystic kidneys), were studied. Thirty—four received their
care at the Oregon Health Sciences University, 15 at the
Portland Veterans Administration Hospital and 81 were re-
ferred to our center for renal transplant evaluation. Eighty—
three patients were treated at some time with hemodialysis and
17 additional patients were treated with chronic ambulatory
peritoneal dialysis (CAPD) as their only form of dialysis. There
were 66 males and 34 females. Mean age was 46 14 sD years
and mean length of time on dialysis was 36 30 months.
Nineteen patients underwent renal ultrasonography only, 10
underwent computerized tomography (CT) only, and 71 pa-
tients had both renal ultrasonography and CT scan to determine
the presence of renal cysts (Table I).
We also studied 30 patients with advanced chronic renal
failure who had never received any form of dialysis therapy (20
male, 10 female). These patients were approaching end—stage
renal disease and were referred for renal transplant evaluation.
Renal ultrasonography and CT scan were performed in all.
Their mean age was 37 8 years and the mean serum urea
nitrogen (SUN) was 89 20 mg/dl.
Imaging studies
Received for publication May 31, 1985,
and revised forms November 4, 1985 and March 10, 1986
© 1986 by the International Society of Nephrology
Real time and static ultrasonic scanners with a transducer
frequency between 3.5 and 5 megaHz were used. Scans were
performed in cross—section, longitudinal, coronal and, if neces-
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Table 1. Clinical characteristics of 100 dialysis patients
Patients on hemodialysis 83
Patients on CAPD as only dialysis modality 17
Age 46 14 years
Time on dialysis 36 30 months
Values are mean SaM
Table 2. Prevalence of renal cystic disease
Number of cysts Number of patients %
Dialysis patientsN = 100
Predialysis patientsN = 30
0
1—3
ARCD
0
1—3
ARCD
48
30
22
12
16
2
(48)
(30)
(22)
(40)
(53)
(7)
a One patient treated with CAPD only
near water density (—10 to +20 Housenfeld units); 2) no
measurable thickness of the cyst wall; and 3) smooth interface
with renal parenchyma [17]. Clinical variables analyzed were
age, serum urea nitrogen, hematocrit, length of time on dialysis
and underlying primary renal disease divided into five general
categories, including: tubulointerstitial disease, glomerular dis-
ease, diabetes, hypertension, and miscellaneous. Data were
analyzed by analysis of variance and chi square using the
statistical package for the social sciences [18].
Results
Fig. 1. CT scan of the renal fossae of a patient with chronic renal
failure secondary to reflux nephropathy and left unilateral nephrec-
tomy. The left renal fossae is normal without its kidney. The right
kidney reveals multiple cystic structures in the cortex. This patient had
never received any form of dialysis therapy.
sary, oblique planes from anterior and posterior regions. The
images obtained were evaluated by a radiologist (MR) who did
not know the patient's clinical history. A GE 9800 computer-
ized tomographic scanner was used to evaluate the kidneys
bilaterally. No distinction was made between those patients
with residual renal function and those without, and intravenous
contrast agents were avoided to prevent any further loss of
renal function. Twenty percent of patients received oral con-
trast agents. The renal fossae were scanned in 10 mm thick
slices with an interval of 10 mm. The images were viewed with
a wide range window and level. Data were stored and evaluated
by an investigator (MR) unaware of the clinical history.
Diagnosis of cysts
The number of cysts present in each kidney was recorded.
Because of the high prevalence of one or two cysts in kidneys
of the normal aging population, we chose to conservatively
define acquired renal cystic disease as the presence of four or
more cysts in each kidney on either ultrasonography or CT
scan. Ultrasonographic criteria for a firm or presumptive diag-
nosis of renal cysts were: absence of internal echoes; a smooth,
sharply—defined far cyst wall; and the presence of acoustic
enhancement [171. Computerized tomography criteria for the
diagnosis of a cyst were: 1) homogeneous attentuation value
The prevalence of acquired renal cystic disease in the 100
dialysis patients is shown in Table 2. Forty—eight (48%) patients
did not have any cysts. Thirty patients (30%) had one to three
cysts in one or both kidneys. Twenty—two patients (22%) had
multiple bilateral cystic changes in the kidneys consistent with
acquired renal cystic disease. Of these 22 patients, one had
been treated by chronic ambulatory peritoneal dialysis as his
only dialysis modality for a period of seven months. No renal
tumors were observed in these 100 patients.
The prevalence of renal cysts in 30 patients with advanced
chronic renal failure is also shown in Table 2. Twelve patients
(40%) had no renal cysts, 16 patients (53%) had one to three
cysts in one or both kidneys. Two patients (7%) had multiple
bilateral cystic changes in kidneys consistent with acquired
renal cystic disease. One of these patients with ARCD was a
36-year—old male who had refiux nephropathy and had under-
gone a left unilateral nephrectomy 16 years previously. Light
microscopy of the nephrectomy specimen revealed changes of
chronic interstitial nephritis and mild fibrosis. No evidence of
any cystic changes were noted. He had had a serum creatinine
greater than 3.0 mg/dl for approximately 10 years. CT scan and
renal ultrasonography during the present study revealed the left
renal fossa without its kidney and the right kidney with numer-
ous small cysts throughout the cortex and medulla (Fig. 1). The
second patient with ARCD was a 37-year-old male who under-
went a percutaneous renal biopsy four years earlier, which
revealed IgA nephropathy and no evidence of cystic disease.
He had had a serum creatinine greater than 3.0 mg/dl for four
years. CT scan and renal ultrasonography revealed multiple
bilateral cysts. No renal tumors were noted in any of these 30
patients.
Clinical variables analyzed in the 100 dialysis patients are
shown in Table 3. The average age was 55 4 years in the
ARCD group, compared to 45 2 years for those with one to
three cysts, and 42 2 years for those with no cysts. The
average length of dialysis therapy was 49 8 months for the
group with ARCD. This is significantly (P < 0.05) longer than
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the 15 + 3 months of dialysis therapy in patients with no cysts.
Patients with one to three cysts were treated with dialysis an
average of 28 6 months, intermediate between the other two
groups. Twenty—one of 66 dialyzed males (32%) had ARCD
(Table 4), seventeen (17 of 66) had one to three cysts, and 28
patients (28 of 66) had no cysts. One of 34 dialyzed female
patients (3%) had ARCD compared to 13 of 34 females with one
to three cysts, and 20 of 34 females without cysts. Among the 22
patients with ARCD, 21 were male and one was female (P <
0.001). There was no significant differences in gender in the
group with one to three cysts or the group with zero cysts.
There were no significant differences in hematocrit, serum urea
nitrogen, or underlying primary renal disease in patients with
ARCD when compared to patients without cysts or those with
one to three cysts. Compared to dialysis patients without any
cysts, dialysis patients with ARCD were significantly older (P <
0.05) and had been on dialysis significantly longer (P < 0.05).
Table 5 demonstrates the clinical variables in 30 patients (20
male, 10 female) not yet on dialysis therapy. There were no
differences in age, hematocrit or serum urea nitrogen, nor was
there a difference in the nature of the underlying renal disease
among patients with ARCD when compared to those with no
cysts or those with one to three cysts. Of the two out of 30
predialysis patients with ARCD, both were male (two of 20
male patients). There were eight males (eight of 20) with no
cysts and 10 with one to three cysts (Table 4). There were no
females with ARCD in the nondialyzed, chronic renal failure
group. There were six females (six of 10) with one to three cysts
and four females (four of 10) with no cysts.
Of the 130 patients with chronic renal failure (dialyzed = 100,
nondialyzed — 30) evaluated in this study, 21 of 86 males had
ARCD, while only one of 44 females had ARCD (P < 0.001),
indicating a preponderance of male patients who developed this
disease.
The accuracy of renal ultrasonography was compared to
computerized tomography. CT scan of the kidneys is purported
to be 100% accurate in the characterization of renal cysts [17,
19, 20]. Therefore, we compared ultrasound to CT scan. One
hundred and one patients (dialyzed and nondialyzed) had both
Discussion
Until recently, little attention had been given to the con-
tracted kidneys of chronic dialysis patients. In 1977, Dunnill
and colleagues found multiple renal cysts at autopsy in 14 of 30
hemodialysis patients. These patients did not have autosomal
dominant polycystic kidney disease or other cystic disorders at
the start of dialysis therapy. These authors postulated that these
cysts were acquired and possibly were a consequence of
maintenance hemodialysis [1]. Several authors have subse-
quently observed similar cysts in patients with a variety of renal
diseases maintained on hemodialysis [1, 3—15].
Surgical and autopsy tissues, ultrasonography, and comput-
erized tomography have all been employed to diagnose ARCD
in dialysis patients. Through 1984, 14 series were reported using
a variety of diagnostic criteria demonstrating the presence of
ARCD in 262 of 601 chronic dialysis patients, an overall
incidence of 43.6% (1, 3—16). In the present study, ARCD was
present in 22% of our dialysis patients.
Previously, it was not clear whether hemodialysis treatments
were a prerequisite or whether prolonged renal failure per se
could lead to the formation of these cysts. The present study
clearly documents that acquired renal cystic disease may occur
in patients with chronic renal failure who have never been
dialyzed.
Among dialysis patients the development of ARCD appears
to be related to the duration of hemodialysis. Our study is in
agreement with previous observations that the proportion of
patients with cysts and the number of cysts increase with
increasing duration of dialysis therapy. Studies have also doc-
umented a correlation between progressive increase in the size
of cysts and duration of dialysis (6, 15, 22, 23). We did not
systematically assess the size of cysts in our study. The
incidence of ARCD appears to be much lower in those patients
who have been dialyzed for less than three years. One to three
renal cysts occur in both predialysis and dialysis patients with
approximately the same frequency with which they occur in the
general population [10]. However, the number of cysts may
increase with time. Longitudinal studies will be necessary to
define disease progression, if it exists.
Table 3. Clinical variables in 100 dialysis patients
Age years
Time on dialysis months
Hematocrit %
Serum urea nitrogen mgldl
0 Cysts 1—3 Cysts ARCD
42 2
15 + 3
29 I
72 3
45 228 6
30 1
64 4
Table 5. Clinical variables in 30 predialysis patients
P < 0.05 compared to 0 cyst group
Values are mean ÷ SEM
Table 4. Gender differences in acquired renal cystic disease
36 3
31 175 6
Number of cysts
Dialysis patients 0
N= 100 1—3
ARCD
Predialysis patients 0
N—30 1—3
0 Cysts 1—3 Cysts ARCD
55 4 Age years 37 3 37 149 8" Hematocrit % 33 2 34
28 1 Serum urea nitrogen mg/c/i 101 9 91 ÷ 1
71±6 - _____________
Values are mean SEM
an ultrasound and CT scan evaluation of the renal fossae.
Eighteen patients (18 of 101) were found to have ARCD by
either ultrasonography or CT scan. In those patients with
Male Female ARCD, ultrasound was positive in 13 of the 18 patients and CT
28 20 was positive in 17 of the 18 patients. It is interesting to note that
17 13 one patient had a negative CT scan and a positive ultrasound.
21 1 Forty patients (40 of 101) were found to have one to three
10
cysts by either US or CT. Ultrasound was positive in 26 of the
2 0 40 patients, and CT scan was positive in 25 of the 40 patients. In
only 11 of the 40 patients did both the US and CT agree to the
presence of one to three renal cysts.
ARCD
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The incidence of ARCD appears to be increased in males on
dialysis therapy. This is in agreement with the study by
Ishikawa et al, showing an increase in kidney volume and
severity of cystic changes over time in males on dialysis [21]. In
the females, the rate of increase in kidney volume was small and
the progression of cystic changes not as severe.
Acquired renal cystic disease is characterized by multiple
cysts that predominate in the renal cortex, but also involve the
renal medulla. Cysts in acquired renal cystic disease are usually
less than 0.5 cm in diameter; however, they can become as large
as 2.5 to 3.0 cm in diameter [7, 8, 11]. Both x-ray tomography
and ultrasonography are inadequate to visualize these small
cysts. Detection of small cysts by ultrasonography is very
difficult in scarred kidneys without a homogeneous structure
[4]. On the other hand, computerized tomography is reliable
and sensitive enough to detect cysts 0.3 to 0.5 cm in diameter.
McClennan and co-workers have shown that CT is 100%
accurate in the characterization of renal cysts identified by
urography, and confirmed by cyst puncture using the same
criteria as in this study [17]. The diagnosis of benign renal cysts
by CT scan has also been confirmed by needle aspiration or at
the time of surgery performed for other reasons [24]. Some
authors suggest that ultrasonography and CT scan provide
similar diagnostic information regarding autosomal dominant
polycystic kidney disease, and in some instances CT scan will
provide information not obtainable by ultrasonography [25—27].
This appears to be true for ARCD as well. It should be noted
that in one patient with ARCD, a positive ultrasound was not
confirmed by CT. This can be interpreted as either a false
positive ultrasound or a false negative CT scan. For our patients
with only one to three cysts, both ultrasonography and CT scan
were often inaccurate. We feel that a combination of a negative
CT scan and a negative ultrasonographic examination would be
more accurate in definitively excluding ARCD.
The mechanisms leading to the formation of cysts in ARCD
are unclear. Altered compliance of tubular basement membrane
induced by retained cystogenic substances [28] and obstruction
of tubules by proliferation of tubular epithelium, interstitial
fibrosis, or intratubular oxalate crystals have been proposed as
the cause of renal cyst formation in ARCD [10]. Feiner et al
examined renal tissue from patients with ARCD and observed
continuity between cysts and tubules, and suggested that cysts
begin as fusiform tubular dilatations or as saccular tubular
outpouchings [7]. It has been postulated that toxic substances
accumulating in chronic renal failure (and perhaps not cleared
by dialysis) cause cystic dilatations by stimulating focal prolif-
eration of tubular epithelium, leading to tubular obstruction or
altering the tubular basement membrane in such a way as to
lead to outpouchings of the tubular basement membrane [11].
It is interesting to note the male preponderance in the
incidence of ARCD. Gender differences have also been de-
scribed in renal metabolism, aminoglycoside nephrotoxicity,
and renal hypertrophy [29—31]. Perhaps male hormones have a
role in predisposing or accentuating tubular epithelial hyperpla-
sia leading to ARCD formation.
Biologically active substances not cleared by dialysis may
stimulate cellular proliferation. This hypothesis is supported by
the finding that successful renal transplantation in dialysis
patients with ARCD leads to regression of cysts and a reduction
in size of the affected kidneys, presumably by removing the
stimulus to cyst production [32]. Experimentally—induced renal
cysts in rats given diphenylthiazole also disappear after drug
withdrawal [33]. It has been shown that mitogenic polyamines
in uremic dialysis patients increased smooth muscle prolifera-
tion in arterial walls [34]. Unduly vigorous cell proliferation
induced by these substances may account for the high incidence
of renal adenomas and carcinomas.
The consequences of cystic transformation are clinically very
important. Hemorrhage into the cysts of ARCD may occur
because of rupture of unsupported sclerotic vessels that project
into cysts [7]. Heparinization and prolonged bleeding times in
uremia may further contribute to the incidence and severity of
hemorrhage [11]. Bleeding from the cysts is not always confined
to the cyst cavity since subcapsular and perinephric hemor-
rhage have also been described [11].
Cysts also provide a nidus for the formation of stones
because of stagnation of fluid [4]. Acquired renal cysts are
commonly the site of calcium oxalate deposition [1, 8, 10].
Cysts in ARCD are lined by simple cuboidal or columnar
epithelium. Many of these cysts also demonstrate hyperplasia
and multilayering of the epithelium lining, along with papillary
projections, suggestive of tumor formation. Mitoses in the
epithelial cells are observed often. Solid renal tumors, often
multiple in origin, have been documented in approximately
16.4% of patients with ARCD [16]. While most tumors are
adenomas, five percent of tumors have been adenocarcinomas
[15, 16, 35]. Presumably these tumors arise from the foci of
proliferating tubular epithelial cells in close association with
cysts or even within cysts. Because of these important clinical
consequences of ARCD, it is important to accurately diagnose
the presence of this entity. In our study of these 130 patients,
we did not detect any patients with tumor formation by either
ultrasonography or CT scan. Although CT scan is accurate in
detecting small renal tumors, they may have been missed
because of our decision to avoid intravenous contrast agents.
We have recently observed a patient who has never dialyzed
but who has ARCD and an adenocarcinoma in his right cystic
kidney (not included in data).
In conclusion, acquired renal cystic disease occurs com-
monly in patients with chronic renal failure and hemodialysis is
not a prerequisite for their development. Patients with ARCD
are generally older and have been on dialysis longer than
patients without cysts. ARCD appears to be more common in
the male dialysis population. One to three cysts occur in both
predialysis and dialysis patients with approximately the same
frequency as they occur in the general population. This may be
a stage in the development of ARCD and longitudinal studies
are necessary to ascertain this progression, if any. Finally, the
diagnosis of ARCD can be excluded definitively when both the
ultrasound and CT scan are negative.
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